Physician profile
Sumit Saraf
NPI 1619132446
$2,777.59
in general payments reported to CMS, 2019-2025
20 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,018 · 2020: $12.10 · 2021: $12.87 · 2022: $54.80 · 2023: $372 · 2024: $49.34 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,593.27 | 2019-2025 | |
| Abbvie INC. | $177.89 | 2019-2020 | |
| Coopersurgical, INC. | $156.48 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Sumitomo Pharma America, INC. | $142.27 | 2023 | Myfembree |
| Caldera Medical, INC | $133.75 | 2019 | |
| Astellas Pharma US INC | $132.69 | 2023 | Veozah |
| Lupin INC. | $106.01 | 2019 | |
| Aspira Women'S Health INC | $84.16 | 2023 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $29.61 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $26.83 | 2021-2022 | |
| Hydrofera LLC | $24.70 | 2025 | Hydrofera Blue |
| Dexcom, INC. | $23.30 | 2025 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $22.27 | 2022 | |
| Allergan, INC. | $21.38 | 2019 | |
| Solventum Corporation | $20.39 | 2025 | Prevena |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.89 | 2024 | Ligasure |
| Myovant Sciences INC. | $18.57 | 2022 | |
| Mission Pharmacal Company | $16.89 | 2019 | |
| Exeltis, USA INC. | $14.21 | 2024 | Slynd |
| Organon LLC | $14.03 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Saraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.